๐ต๏ธ Elevance Health, Inc. ($ELV)
SEC insider & ownership activity, last 12 months ยท CIK 1156039 ยท every row links its SEC filing
Over the last 12 months insiders sold $1.7M against $2.6M of open-market buying. Boudreaux Gail bought $1.0M in discretionary trades (Jul). 1 planned sale is pending, the largest $630K (Clark R Kerry). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
4 buyers, $2.6M (5 lots) ยท 4 sellers, $1.7M (5 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Boudreaux Gail | 2 | $1.0M | 0 | โ | Jul 17, 2026 |
| Charles Morgan Kendrick | 0 | โ | 1 | $911K | Mar 6, 2026 |
| Steven H. Collis | 1 | $870K | 0 | โ | Mar 5, 2026 |
| Ronald William Penczek | 0 | โ | 2 | $766K | Jun 12, 2026 |
| Susan D. Devore | 1 | $375K | 0 | โ | Aug 19, 2025 |
| Ramiro G. Peru | 1 | $366K | 0 | โ | Jul 17, 2026 |
| Robert L. Dixon Jr. | 0 | โ | 1 | $61K | Jun 11, 2026 |
| Amy W. Schulman | 0 | โ | 1 | $7K | Mar 12, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Blackrock, Inc. | 7.8% | 13G | Apr 17, 2025 | filing โ | |
| Vanguard Capital Management | 7.1% | 13G | Apr 29, 2026 | filing โ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Clark R Kerry | $630K | Jul 7, 2026 | filing โ |
| Ronald William Penczek | $149K | Jun 12, 2026 | filing โ |
| Robert L. Dixon Jr. | $61K | Jun 11, 2026 | filing โ |
| Ronald William Penczek | $617K | May 19, 2026 | filing โ |
| Charles Morgan Kendrick | $911K | Mar 6, 2026 | filing โ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Jul 15, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jul 15, 2026 | filing โ |
| Reg FD disclosure (7.01) | Jun 10, 2026 | filing โ |
| Shareholder vote (5.07) | May 13, 2026 | filing โ |
| Earnings (2.02) | Apr 22, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Apr 22, 2026 | filing โ |
| Reg FD disclosure (7.01) | Mar 10, 2026 | filing โ |
| Other events (8.01) | Mar 2, 2026 | filing โ |
| Officer/director changes (5.02) | Feb 26, 2026 | filing โ |
| Reg FD disclosure (7.01) | Feb 26, 2026 | filing โ |
| Earnings (2.02) | Jan 28, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jan 28, 2026 | filing โ |
| Officer/director changes (5.02) | Dec 10, 2025 | filing โ |
| Reg FD disclosure (7.01) | Nov 10, 2025 | filing โ |
| Earnings (2.02) | Oct 21, 2025 | filing โ |
| Financial Statements and Exhibits (9.01) | Oct 21, 2025 | filing โ |
| Other events (8.01) | Sep 8, 2025 | filing โ |
| Financial Statements and Exhibits (9.01) | Sep 8, 2025 | filing โ |
| Reg FD disclosure (7.01) | Sep 4, 2025 | filing โ |